---
title: "李嘉誠向三間醫院提供30個組織碎化技術腎臟癌臨床試驗名額 — DecisionGateway"
description: "Li Ka Shing is funding 30 clinical trial places at three Hong Kong hospitals so patients with kidney cancer can be treated with histotripsy, making Hong Kong th"
canonical_url: "https://dgw.tmarket.io/decisions/01a1e96c-9799-7a2a-919b-9fbf704f1b24"
meta:
  "og:description": "Li Ka Shing is funding 30 clinical trial places at three Hong Kong hospitals so patients with kidney cancer can be treated with histotripsy, making Hong Kong th"
  "og:image": "https://dgw.tmarket.io/og.jpg"
  "og:image:alt": "White network of connected nodes crossed by a timeline on black"
  "og:image:height": "1024"
  "og:image:width": "1024"
  "og:title": "李嘉誠向三間醫院提供30個組織碎化技術腎臟癌臨床試驗名額 — DecisionGateway"
  "twitter:image": "https://dgw.tmarket.io/og.jpg"
---

> Index of every page on this site: [llms.txt](https://dgw.tmarket.io/llms.txt)

**Decision**/Other

**Adopted**

# **李嘉誠向三間醫院提供30個組織碎化技術腎臟癌臨床試驗名額**

Li Ka Shing is funding 30 clinical trial places at three Hong Kong hospitals so patients with kidney cancer can be treated with histotripsy, making Hong Kong the first city in Asia to run such a trial.

Trajectories

Mine up to three arcs for this record — target, direction, probability, horizon.

## **Actors and targets**

[李嘉誠基金會proposer](https://dgw.tmarket.io/actors/01a1e96c-9779-7670-815e-9277f175374e)

Targets [香港中文大學醫院actor](https://dgw.tmarket.io/actors/01a1e96c-9783-7e0b-ac9f-7639a98759cc) [港怡醫院actor](https://dgw.tmarket.io/actors/01a1e96c-9789-77e7-aa9d-2308cb79b8f3) [養和醫院actor](https://dgw.tmarket.io/actors/01a1e96c-978f-786e-9020-ef7d186a5a92)

[**李嘉誠基金會 dossier **](https://dgw.tmarket.io/actors/01a1e96c-9779-7670-815e-9277f175374e)

## **Source**

> 李嘉誠將向香港中文大學醫院、港怡醫院及養和醫院提供30個臨床試驗名額

*rthk\_new\_c · Telegram [ Open post](https://t.me/rthk_new_c/401274)*

## **Not established**

- Total funding amount
- Trial duration and end date
- Patient eligibility criteria
- Whether the 30 places are split evenly among the three hospitals

## **Extracted detail**

## **Related decisions**

Same kind only, ranked by embedding similarity to this record.

```json
{"@context":"https://schema.org","@graph":[{"@id":"https://dgw.tmarket.io/#website","@type":"WebSite","description":"Decisions, events and falsifiable forecasts — every claim cited to its public source. Read free.","name":"DecisionGateway","url":"https://dgw.tmarket.io/","publisher":{"@id":"https://dgw.tmarket.io/#identity"}},{"@id":"https://dgw.tmarket.io/decisions/01a1e96c-9799-7a2a-919b-9fbf704f1b24#webpage","@type":"WebPage","description":"Li Ka Shing is funding 30 clinical trial places at three Hong Kong hospitals so patients with kidney cancer can be treated with histotripsy, making Hong Kong th","name":"李嘉誠向三間醫院提供30個組織碎化技術腎臟癌臨床試驗名額 — DecisionGateway","url":"https://dgw.tmarket.io/decisions/01a1e96c-9799-7a2a-919b-9fbf704f1b24","breadcrumb":{"@id":"https://dgw.tmarket.io/decisions/01a1e96c-9799-7a2a-919b-9fbf704f1b24#breadcrumb"},"isPartOf":{"@id":"https://dgw.tmarket.io/#website"},"potentialAction":[{"@type":"ReadAction","target":["https://dgw.tmarket.io/decisions/01a1e96c-9799-7a2a-919b-9fbf704f1b24"]}]},{"@id":"https://dgw.tmarket.io/#identity","@type":"Organization","name":"DecisionGateway","url":"https://dgw.tmarket.io"},{"@id":"https://dgw.tmarket.io/decisions/01a1e96c-9799-7a2a-919b-9fbf704f1b24#breadcrumb","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","name":"Home","item":"https://dgw.tmarket.io","position":1},{"@type":"ListItem","name":"Feed","item":"https://dgw.tmarket.io/feed","position":2},{"@type":"ListItem","name":"李嘉誠向三間醫院提供30個組織碎化技術腎臟癌臨床試驗名額","position":3}]}]}
```

## Sitemap

See the full [sitemap](https://dgw.tmarket.io/sitemap.md) for all pages.
